A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia. - Bergua Jm, Pau Montesinos, David Martinez Cuadrón, Pascual Fernández Abellán, Josefina Serrano, Sayas Mj, María J. Sayas, Julio Prieto Fernandez, Raimundo García, Ana J. García-Huerta, Manuel Pérez Encinas, Adriana Simiele, Gabriela Rodríguez Macias, Pilar Herrera Puente, Martínez Sánchez Mp - Dissemin

Language
Login

Published in

Wiley, British Journal of Haematology, 5(174), p. 700-710, 2016

DOI: 10.1111/bjh.14107

Links

ORCID
Wiley

Tools

Export citation

Search in Google Scholar

A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.

Journal article published in 2016 by Bergua Jm, Pau Montesinos, David Martinez Cuadrón, Pascual Fernández Abellán, Josefina Serrano, Sayas Mj, María J. Sayas, Julio Prieto Fernandez, Raimundo García, Ana J. García-Huerta, Manuel Pérez Encinas, Adriana Simiele, Gabriela Rodríguez Macias, Pilar Herrera Puente, Martínez Sánchez Mp and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO